The Expression of miRNAs in Sudanese Patients with Systemic Lupus Erythematosus in Khartoum State

作     者：Sarah Mohammed Dafalla Ahmed Elhadi Elsadig Tarig A. M. Hamid Huda Mohamed Haroun Sana Eltahir Abdalla Sarah Mohammed Dafalla;Ahmed Elhadi Elsadig;Tarig A. M. Hamid;Huda Mohamed Haroun;Sana Eltahir Abdalla

作者机构：Department of Haematology Medical Laboratory Sciences Program Alyarmouk College Khartoum Sudan Department of Haematology Faculty of Medical Laboratory Sciences Alzaiem Al Azhari University Khartoum Sudan Department of Haematology and Immunohematology Sharq El Nile College Khartoum North Sudan Department of Haematology Faculty of Medical Laboratory Sciences University of Gezira Madani Sudan Department of Pathology Faculty of Medicine Al Neelain University Khartoum Sudan 

出 版 物：《Open Journal of Rheumatology and Autoimmune Diseases》 (风湿病与自身免疫疾病期刊（英文）)

年 卷 期：2022年第12卷第4期

页      面：128-136页

学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

主　　题：Systemic Lupus Erythematosus (SLE) MicroRNAs 

摘      要：Background: MicroRNAs (miRs) are noncoding gene regulators that may have a role as diagnostic or prognostic biomarkers in systemic lupus erythematosus (SLE). Aim: To measure the blood levels of miR-146a, miR-126 and miR-30a in Sudanese SLE patients and to investigate their potential role in disease pathogenesis and utility as biomarkers for SLE. Material and Methods: A total of 48 SLE patients and 20 matched healthy individuals were enrolled in this study. SLE disease activity index (SLEDAI) was assessed. The blood levels of miR-146a, miR-126 and miR-30a were determined by Real-time polymerase chain reaction (PCR) in all participants. Γ-INF and IL-2 were analyzed by ELISA, and CD markers were used in flow cytometry. Results: The mean age of the patients was 31.5 ± 8.5 years with disease duration 5 years. In SLE patients, the mean blood level fold changes of miR-146a (0.33 ± 0.277;P 0.305) compared to controls. Down regulation of miR-146a increase expression of γ-INF (P 0.05) as no differences between the SLE patients and healthy control. Conclusion: Circulating miR-146a and miR-126 could be a potential noninvasive biomarker in SLE. This study provides an overview of the current state of research on the role of miRNAs in the immune pathogenesis and regulation of SLE. Further studies are needed in miRNAs profiling expressions of SLE diseases.